| Lisa Earnest Ishii, MD | |
|
601 N Caroline St, Baltimore, MD 21287-0006 | |
| (410) 955-4985 | |
| Not Available |
| Full Name | Lisa Earnest Ishii |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 24 Years |
| Location | 601 N Caroline St, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831258052 | NPI | - | NPPES |
| 409108600 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | D63546 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for linaclotide for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation.
Soils from one of the highest, driest places on earth harbor microorganisms with the potential to treat HIV and tackle the world's antibiotic time bomb, research from Newcastle University, UK, has revealed.
inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, today announced that it has signed a definitive agreement to acquire Kforce Clinical Research, Inc. ("KCR"), a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies, from Kforce Inc. for $50 million in cash.
A new study released as a preprint on the medRxiv* server throws cold water on this notion, however, by demonstrating that in a set of asymptomatic cases, less than a tenth actually had evidence of SARS-CoV-2 infection. This finding has serious implications for the practices mentioned above, since they may be neither justifiable nor cost-effective as means to break the chain of viral transmission.
Regenstrief research scientists Christopher Callahan, M.D., and Alexia Torke, M.D., will play a key role in a major nationwide effort to improve healthcare and quality of life for people with Alzheimer's disease and related dementias.
› Verified 8 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for linaclotide for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation.
Soils from one of the highest, driest places on earth harbor microorganisms with the potential to treat HIV and tackle the world's antibiotic time bomb, research from Newcastle University, UK, has revealed.
inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, today announced that it has signed a definitive agreement to acquire Kforce Clinical Research, Inc. ("KCR"), a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies, from Kforce Inc. for $50 million in cash.
A new study released as a preprint on the medRxiv* server throws cold water on this notion, however, by demonstrating that in a set of asymptomatic cases, less than a tenth actually had evidence of SARS-CoV-2 infection. This finding has serious implications for the practices mentioned above, since they may be neither justifiable nor cost-effective as means to break the chain of viral transmission.
Regenstrief research scientists Christopher Callahan, M.D., and Alexia Torke, M.D., will play a key role in a major nationwide effort to improve healthcare and quality of life for people with Alzheimer's disease and related dementias.
› Verified 8 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1235733445 PECOS PAC ID: 1052223229 Enrollment ID: O20201221001668 |
News Archive
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for linaclotide for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation.
Soils from one of the highest, driest places on earth harbor microorganisms with the potential to treat HIV and tackle the world's antibiotic time bomb, research from Newcastle University, UK, has revealed.
inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, today announced that it has signed a definitive agreement to acquire Kforce Clinical Research, Inc. ("KCR"), a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies, from Kforce Inc. for $50 million in cash.
A new study released as a preprint on the medRxiv* server throws cold water on this notion, however, by demonstrating that in a set of asymptomatic cases, less than a tenth actually had evidence of SARS-CoV-2 infection. This finding has serious implications for the practices mentioned above, since they may be neither justifiable nor cost-effective as means to break the chain of viral transmission.
Regenstrief research scientists Christopher Callahan, M.D., and Alexia Torke, M.D., will play a key role in a major nationwide effort to improve healthcare and quality of life for people with Alzheimer's disease and related dementias.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Earnest Ishii, MD Po Box 64588, Baltimore, MD 21264-4588 Ph: (410) 550-0460 | Lisa Earnest Ishii, MD 601 N Caroline St, Baltimore, MD 21287-0006 Ph: (410) 955-4985 |
News Archive
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for linaclotide for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation.
Soils from one of the highest, driest places on earth harbor microorganisms with the potential to treat HIV and tackle the world's antibiotic time bomb, research from Newcastle University, UK, has revealed.
inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, today announced that it has signed a definitive agreement to acquire Kforce Clinical Research, Inc. ("KCR"), a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies, from Kforce Inc. for $50 million in cash.
A new study released as a preprint on the medRxiv* server throws cold water on this notion, however, by demonstrating that in a set of asymptomatic cases, less than a tenth actually had evidence of SARS-CoV-2 infection. This finding has serious implications for the practices mentioned above, since they may be neither justifiable nor cost-effective as means to break the chain of viral transmission.
Regenstrief research scientists Christopher Callahan, M.D., and Alexia Torke, M.D., will play a key role in a major nationwide effort to improve healthcare and quality of life for people with Alzheimer's disease and related dementias.
› Verified 8 days ago
Dr. David Jeffrey Eisenman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 16 S Eutaw St, Suite 500, Baltimore, MD 21201 Phone: 410-328-5828 Fax: 410-328-5827 | |
Dr. John R Saunders Jr., M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 6569 N Charles St, Suite 401, Baltimore, MD 21204 Phone: 443-849-8940 | |
Dr. John F. Biedlingmaier, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-6897 Fax: 410-328-2109 | |
Dr. David W Eisele, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St, Jhoc 6215, Baltimore, MD 21287 Phone: 410-955-1080 | |
Andrew Lane, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-1686 | |
Arain A. Waseem, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1576 Merritt Blvd, Suite # S-6, Baltimore, MD 21222 Phone: 410-282-7788 | |
Tony Yan, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 6700 Ridge Rd, Suite 3, Baltimore, MD 21237 Phone: 410-391-3434 Fax: 410-574-7574 |